| 期刊全稱 | Biomarkers for Preclinical Alzheimer’s Disease | | 影響因子2023 | Robert Perneczky | | 視頻video | http://file.papertrans.cn/188/187800/187800.mp4 | | 發(fā)行地址 | Includes cutting-edge methods and protocols.Provides step-by-step detail essential for reproducible results.Contains key notes and implementation advice from the experts | | 學(xué)科分類 | Neuromethods | | 圖書(shū)封面 |  | | 影響因子 | .This volume discusses the importance of imaging, fluid, and genetic biomarkers in detecting the earliest pre-symptomatic stages of Alzheimer’s disease (AD). The chapters in this book are separated into five parts. Part one explores the reasons why we need improved approaches for early detection and diagnosis of AD. Part two describes clinical and research techniques for preclinical AD diagnosis. Part three looks at the current methods in use to diagnose AD and how they can also be used for early detection in healthy older individuals. Parts four and five talk about technological advancements in AD diagnosis and ethical considerations in AD research. In .Neuromethods. series style, chapters include the kind of detail and key advice from the specialists needed to get successful results in your laboratory..Comprehensive and cutting-edge, .Biomarkers for Preclinical Alzheimer’s Disease. is a valuable resource for individuals interested in the use of biomarker strategies to improve early AD detection. This book will be of great interest to researchers and clinicians from both academia and industry.”. | | Pindex | Book 2018 |
The information of publication is updating
|
|
|Archiver|手機(jī)版|小黑屋|
派博傳思國(guó)際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-10 01:24
發(fā)表于 2025-3-21 18:11:25
